Patents by Inventor Young Chen

Young Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260097367
    Abstract: A method for cleaning a filter includes flowing a cleaning fluid through a filter housing to clean the filter in the filter housing and obtaining flowing parameters of the cleaning fluid. The method further includes determining a condition of the filter based on the flowing parameters of the cleaning fluid, and associating the flowing parameters to attributes of the filter when the condition of the filter is clean.
    Type: Application
    Filed: October 8, 2024
    Publication date: April 9, 2026
    Applicant: Taiwan Semiconductor Manufacturing Company, Ltd.
    Inventors: Yi-Lung CHUNG, Heng-Yi TSENG, Shun Chan TENG, Chih-Cheng HUNG, Tsung-Han LEE, Feng-An YANG, Young CHEN, Sheng Chia KUO, Jung-Huang PENG
  • Publication number: 20250145607
    Abstract: Provided herein are compounds of formula (I) and compositions thereof for modulating CAMKK2. In some embodiments, the compounds and compositions are provided for treatment of cancer and/or obesity.
    Type: Application
    Filed: October 7, 2022
    Publication date: May 8, 2025
    Applicant: Celgene Corporation
    Inventors: Laura Akullian D'Agostino, Brandon Whitefield, Young Chen
  • Publication number: 20240246969
    Abstract: The present invention relates generally to compositions and methods for treating cancer, e.g. by using the compounds of formula (I). Provided herein are substituted bicyclic heteroaryl derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of Calcium/calmodulin-dependent protein kinase kinase 2. Furthermore, the subject compounds and compositions are useful for the treatment of cancer.
    Type: Application
    Filed: May 10, 2022
    Publication date: July 25, 2024
    Inventors: Young Chen, Michael Wallace, Zhe Nie, Laura D'Agostino
  • Patent number: 11028066
    Abstract: The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds as exemplified as follows, The subject compounds and compositions are useful for inhibition of lysine specific demethylase-1. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
    Type: Grant
    Filed: February 3, 2020
    Date of Patent: June 8, 2021
    Assignee: Celgene Quanticel Research, Inc.
    Inventors: Young Chen, Toufike Kanouni, Jeffrey Alan Stafford, James Veal
  • Publication number: 20200172506
    Abstract: The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds as exemplified as follows, The subject compounds and compositions are useful for inhibition of lysine specific demethylase-1. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
    Type: Application
    Filed: February 3, 2020
    Publication date: June 4, 2020
    Applicant: CELGENE QUANTICEL RESEARCH, INC.
    Inventors: Young CHEN, Toufike Kanouni, Jeffrey Alan Stafford, James Veal
  • Publication number: 20200108052
    Abstract: The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of lysine specific demethylase-1. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
    Type: Application
    Filed: December 5, 2019
    Publication date: April 9, 2020
    Applicant: CELGENE QUANTICEL RESEARCH, INC.
    Inventors: Young Chen, Toufike Kanouni, Jeffrey Alan Stafford, James Veal